Japan’s Dementia Drug Market To Expand To 250 Billion By 2020
This article was originally published in PharmAsia News
Executive Summary
Fuji Keizai recently put together a report on the growing dementia drug market in Japan, and concluded that 2011 sales of ¥127.4 billion will double to ¥257.1 billion by the year 2020.